In Brief This Week: BGI, Agilent, ReadCoor, GeneNews | GenomeWeb

NEW YORK (GenomeWeb) – BGI confirmed this week that it has filed for an IPO on the ChiNext exchange, and is seeking to raise $250 million through the issuance of 40 million new shares. According to a Chinese media report, BGI recorded revenues of approximately $250 million and operating profit of about $55 million in 2016.


Agilent Technologies announced this week that its board has approved a quarterly dividend of $.13 per share of common stock to be paid on April 26 to all shareholders of record as of the close of business on April 4.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.